The Danish American who doubted Covid shots is meant to lead drug regulation – but has focused on vaccines ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...

AstraZeneca's MFN pricing agreement with the US government reflects broader efforts to reduce drug prices and enhance ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...

KORU Medical Systems, Inc.KRMD recently announced that it has submitted a 510(k) premarket notification for FDA clearance to ...

Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...

ORLANDO, FL / ACCESS Newswire / December 26, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc.

"What we want to know is what is the pain that you are solving for your customers and who is willing to pay for your solution ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...